SCLC: Inflammation, Immunity & Aggressive Spread

Small cell lung cancer (SCLC), a relentlessly aggressive disease, has long defied effective long-term treatment. While initial responses to chemotherapy are often promising, the near-inevitable relapse and rapid progression have left a significant unmet need for deeper understanding of the cancer’s underlying mechanisms. Now, a breakthrough study from the University of Cologne is shedding light … Read more